Givaudan Stock Forecast for 2023 - 2025 - 2030
Updated on 04/24/2024
Givaudan Stock Forecast and Price Target
The average price target for Givaudan's stock of CHF3850.00 recently provided by eight leading analysts would represent a -3.92% downside from its last closing price if reached. This potential increase is based on a high estimate of CHF4700.00 and a low estimate of CHF2800.00. If you're looking for information on Givaudan stock, consider checking out the forecasts for comparable firms such as NYSE:ALB.
-3.92% Downside
Givaudan Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Givaudan's Price has decreased by 100.00%, from CHF3013.49 to CHF0.00. In the next year, analysts are expecting an increase in Fair Value, predicting it will reach CHF4045.81 – an increase of 100.00%. The Givaudan forecast is for Fair Value to reach CHF6101.09 or grow by 100.00%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
NESN Stock Forecast | Nestlé | Outperform |
11
|
CHF93.98 | Buy/Sell | CHF115.58 | 17.05% |
ULVR Stock Forecast | Unilever PLC | Hold |
8
|
£38.63 | Buy/Sell | £50.61 | 28.55% |
MDLZ Stock Forecast | Mondelez International | Buy |
15
|
$71.31 | Buy/Sell | $83.21 | 14.99% |
BAS Stock Forecast | BASF | Outperform |
12
|
51.32€ | Buy/Sell | 49.50€ | 9.12% |
KHC Stock Forecast | Kraft Heinz | Outperform |
12
|
$38.57 | Buy/Sell | $40.16 | 5.00% |
Givaudan Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Givaudan's Revenue has increased by 9.38%, going from CHF6.32B to CHF6.92B. In the next year, analysts are expecting an increase in Revenue, predicting it will reach CHF7.13B – an increase of 3.10%. The Givaudan forecast is for Revenue to reach CHF10.53B or grow by 52.21%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
BN Stock Forecast | Danone | Outperform |
11
|
59.76€ | Buy/Sell | 55.47€ | 7.10% |
GIS Stock Forecast | General Mills Inc | Hold |
18
|
$71.61 | Buy/Sell | $68.63 | 0.54% |
LONN Stock Forecast | Lonza Group | Buy |
16
|
CHF522.80 | Buy/Sell | CHF516.89 | 11.90% |
Givaudan Dividend per Share Forecast for 2023 - 2025 - 2030
In the last three years, Givaudan's Dividend per Share has grown, increasing from CHF64.00 to CHF68.00 – an increase of 6.25%. For next year, the 18 analysts predict Dividend per Share of CHF71.65, which would mean an increase of 5.37%. Over the next seven years, the pros' prediction is Dividend per Shareof CHF79.00, which would mean a seven-year growth forecast of 16.18%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
HSY Stock Forecast | Hershey Co-The | Hold |
14
|
$188.14 | Buy/Sell | $211.72 | 10.53% |
ADM Stock Forecast | Archer-Daniels-Midland | Hold |
8
|
$61.56 | Buy/Sell | $67.70 | 3.48% |
DD Stock Forecast | DuPont de Nemours | Outperform |
17
|
$73.96 | Buy/Sell | $75.38 | 8.17% |
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
BAYN Stock Forecast | Bayer | Hold |
5
|
26.97€ | Buy/Sell | 45.15€ | 18.65% |
LISN Stock Forecast | Hold |
3
|
CHF103.60k | Buy/Sell | CHF103.73k | 6.18% | |
NZYM B Stock Forecast | Novozymes A/S | Outperform |
18
|
kr387.90 | Buy/Sell | kr365.54 | 12.14% |
Givaudan EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Givaudan's EBITDA has grown, increasing from CHF1.33B to CHF1.36B – a growth of 2.48%. The next year looks promising for Givaudan, with analysts predicting EBITDA of CHF1.61B – an increase of 17.74%. Over the next seven years, experts anticipate that Givaudan's EBITDA will grow at a rate of 67.30%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
ABF Stock Forecast | Associated British Foods | Outperform |
18
|
£27.02 | Buy/Sell | £23.62 | -3.77% |
IFF Stock Forecast | International Flavors & Fragra... | Hold |
15
|
$85.14 | Buy/Sell | $84.46 | 2.18% |
MKC Stock Forecast | McCormick & Company | Hold |
12
|
$75.85 | Buy/Sell | $72.03 | -1.12% |
Givaudan EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Givaudan's EBIT has grown by 8.05%, from CHF1.03B to CHF1.11B. For the next year, analysts are expecting EBIT to reach CHF1.27B – an increase of 13.63%. Over the next seven years, experts predict that EBIT will grow by 73.25%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
K Stock Forecast | Kellanova | Hold |
13
|
$58.75 | Buy/Sell | $59.19 | 2.13% |
SY1 Stock Forecast | Symrise | Outperform |
18
|
104.10€ | Buy/Sell | 106.97€ | 8.55% |
KRZ Stock Forecast | Kerry Group | Outperform |
18
|
79.45€ | Buy/Sell | 96.27€ | 25.24% |
Givaudan EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Givaudan's EPS has decreased by 100.00%, from CHF80.51 to CHF0.00. In the next year, analysts are expecting an increase in EPS, predicting it will reach CHF108.09 – an increase of 100.00%. The Givaudan forecast is for EPS to reach CHF163.00 or grow by 100.00%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
ALB Stock Forecast | Albemarle | Outperform |
11
|
$115.27 | Buy/Sell | $154.93 | 25.79% |
AKZA Stock Forecast | Akzo Nobel N.V. | Outperform |
18
|
62.38€ | Buy/Sell | 79.42€ | 24.24% |
EMN Stock Forecast | Eastman Chemical Co | Outperform |
11
|
$96.36 | Buy/Sell | $96.03 | 4.82% |